Shionogi Of Japan Applies Locally For Kid Version Of Peramivir Flu Drug
This article was originally published in PharmAsia News
Executive Summary
Japan's Shionogi has applied for local approval of its intravenous Rapiacta (peramivir) for treating children's influenza